- Home
- BNR vs BODI Comparison
BNR vs BODI Comparison
Compare BNR & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- BODI
- Stock Information
- Founded
- BNR 2014
- BODI 1998
- Country
- BNR China
- BODI United States
- Employees
- BNR N/A
- BODI N/A
- Industry
- BNR Medical Specialities
- BODI Industrial Machinery/Components
- Sector
- BNR Health Care
- BODI Industrials
- Exchange
- BNR Nasdaq
- BODI Nasdaq
- Market Cap
- BNR 38.3M
- BODI 25.4M
- IPO Year
- BNR 2020
- BODI N/A
- Fundamental
- Price
- BNR $6.13
- BODI $4.55
- Analyst Decision
- BNR
- BODI Buy
- Analyst Count
- BNR 0
- BODI 2
- Target Price
- BNR N/A
- BODI $10.00
- AVG Volume (30 Days)
- BNR 53.5K
- BODI 16.8K
- Earning Date
- BNR 08-21-2025
- BODI 08-05-2025
- Dividend Yield
- BNR N/A
- BODI N/A
- EPS Growth
- BNR N/A
- BODI N/A
- EPS
- BNR N/A
- BODI N/A
- Revenue
- BNR $72,112,038.00
- BODI $371,113,000.00
- Revenue This Year
- BNR $136.32
- BODI N/A
- Revenue Next Year
- BNR N/A
- BODI N/A
- P/E Ratio
- BNR N/A
- BODI N/A
- Revenue Growth
- BNR 0.53
- BODI N/A
- 52 Week Low
- BNR $2.18
- BODI $3.38
- 52 Week High
- BNR $9.48
- BODI $8.71
- Technical
- Relative Strength Index (RSI)
- BNR 56.55
- BODI 60.10
- Support Level
- BNR $6.71
- BODI $3.81
- Resistance Level
- BNR $9.48
- BODI $4.79
- Average True Range (ATR)
- BNR 0.85
- BODI 0.30
- MACD
- BNR 0.17
- BODI 0.06
- Stochastic Oscillator
- BNR 34.46
- BODI 62.73
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.